{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:48:29Z","timestamp":1787582909919,"version":"build-2736575974"},"reference-count":124,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570469"],"award-info":[{"award-number":["81570469"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81620108002"],"award-info":[{"award-number":["81620108002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771732"],"award-info":[{"award-number":["81771732"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81830016"],"award-info":[{"award-number":["81830016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873561"],"award-info":[{"award-number":["81873561"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81922010"],"award-info":[{"award-number":["81922010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.cld.2023.06.003","type":"journal-article","created":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:56:02Z","timestamp":1691801762000},"page":"15-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Autoimmune Hepatitis"],"prefix":"10.1016","volume":"28","author":[{"given":"Zhou","family":"Yuming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tang","family":"Ruqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merrill Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2023.06.003_bib1","doi-asserted-by":"crossref","first-page":"e070201","DOI":"10.1136\/bmj-2022-070201","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"380","author":"Muratori","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.cld.2023.06.003_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"4","author":"Mieli-Vergani","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"10.1016\/j.cld.2023.06.003_bib3","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3109\/00365521.2014.946083","article-title":"Epidemiology and clinical characteristics of autoimmune hepatitis in The Netherlands","volume":"49","author":"van Gerven","year":"2014","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2023.06.003_bib4","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jhep.2018.05.035","article-title":"Family occurrence of autoimmune hepatitis: a Danish nationwide registry-based cohort study","volume":"69","author":"Gronbaek","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2023.06.003_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/liv.13963","article-title":"Extrahepatic autoimmune diseases in patients with autoimmune hepatitis and their relatives: a Danish nationwide cohort study","volume":"39","author":"Gronbaek","year":"2019","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.cld.2023.06.003_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2023.06.003_bib7","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J\u00a0Hepatol"},{"issue":"21","key":"10.1016\/j.cld.2023.06.003_bib8","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3748\/wjg.14.3374","article-title":"Autoimmune liver serology: current diagnostic and clinical challenges","volume":"14","author":"Bogdanos","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2023.06.003_bib9","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.clinre.2012.02.005","article-title":"Autoantibodies in autoimmune hepatitis: antinuclear antibodies (ANA)","volume":"36","author":"Johanet","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"8528","key":"10.1016\/j.cld.2023.06.003_bib10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(87)92024-1","article-title":"Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen","volume":"1","author":"Manns","year":"1987","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cld.2023.06.003_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840180102","article-title":"Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis","volume":"18","author":"Stechemesser","year":"1993","journal-title":"Hepatology"},{"issue":"9214","key":"10.1016\/j.cld.2023.06.003_bib12","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","article-title":"Identification of target antigen for SLA\/LP autoantibodies in autoimmune hepatitis","volume":"355","author":"Wies","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.cld.2023.06.003_bib13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0896-8411(91)90180-K","article-title":"Identification of the main epitope on human cytochrome P450 IID6 recognized by anti-liver kidney microsome antibody","volume":"4","author":"Gueguen","year":"1991","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cld.2023.06.003_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fimmu.2018.00163","article-title":"Autoantibodies in autoimmune hepatitis: can epitopes Tell Us about the etiology of the Disease?","volume":"9","author":"Christen","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.cld.2023.06.003_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejim.2022.11.013","article-title":"Autoimmune serology testing in clinical practice: an updated roadmap for the diagnosis of autoimmune hepatitis","volume":"108","author":"Dalekos","year":"2023","journal-title":"Eur J Intern Med"},{"issue":"5","key":"10.1016\/j.cld.2023.06.003_bib16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2230.2001.00852.x","article-title":"Epitope spreading: protection from pathogens, but propagation of autoimmunity?","volume":"26","author":"Powell","year":"2001","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.cld.2023.06.003_bib17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaut.2011.06.005","article-title":"Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model","volume":"37","author":"Hintermann","year":"2011","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cld.2023.06.003_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000440747","article-title":"Role of histopathology in autoimmune hepatitis","volume":"33","author":"Tiniakos","year":"2015","journal-title":"Dig Dis"},{"issue":"2\u20133","key":"10.1016\/j.cld.2023.06.003_bib19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12016-014-8432-0","article-title":"Emperipolesis mediated by CD8 T\u00a0cells is a characteristic histopathologic feature of autoimmune hepatitis","volume":"48","author":"Miao","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.cld.2023.06.003_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.humpath.2018.07.014","article-title":"Histologic features of autoimmune hepatitis: a critical appraisal","volume":"82","author":"Gurung","year":"2018","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.cld.2023.06.003_bib21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1386-6346(02)00274-7","article-title":"Clinicopathological features of acute-onset autoimmune hepatitis","volume":"25","author":"Okano","year":"2003","journal-title":"Hepatol Res"},{"issue":"5","key":"10.1016\/j.cld.2023.06.003_bib22","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/liv.15217","volume":"42","author":"Lohse","year":"2022","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.cld.2023.06.003_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0676.1994.tb00067.x","article-title":"Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology","volume":"14","author":"Lohr","year":"1994","journal-title":"Liver"},{"issue":"4","key":"10.1016\/j.cld.2023.06.003_bib24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/jcp.2005.028613","article-title":"Liver infiltrating mononuclear cells in children with type 1 autoimmune hepatitis","volume":"59","author":"De Biasio","year":"2006","journal-title":"J\u00a0Clin Pathol"},{"issue":"2","key":"10.1016\/j.cld.2023.06.003_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome-wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","author":"de Boer","year":"2014","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2023.06.003_bib26","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.32417","article-title":"Genome-wide meta-analysis identifies susceptibility loci for autoimmune hepatitis type 1","volume":"76","author":"Li","year":"2022","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2023.06.003_bib27","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.510300611","article-title":"Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition","volume":"30","author":"Pando","year":"1999","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cld.2023.06.003_bib28","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/j.1572-0241.1999.01229.x","article-title":"Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2","volume":"94","author":"Bittencourt","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2023.06.003_bib29","doi-asserted-by":"crossref","first-page":"980768","DOI":"10.3389\/fimmu.2022.980768","article-title":"HLA gut microbiome and hepatic autoimmunity","volume":"13","author":"Beretta-Piccoli","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.cld.2023.06.003_bib30","doi-asserted-by":"crossref","first-page":"1025343","DOI":"10.3389\/fimmu.2022.1025343","article-title":"Type 2 autoimmune hepatitis: genetic susceptibility","volume":"13","author":"Lapierre","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.cld.2023.06.003_bib31","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/hep.31893","article-title":"Human leukocyte antigen profile predicts severity of autoimmune liver disease in children of european ancestry","volume":"74","author":"Ma","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.003_bib32","doi-asserted-by":"crossref","first-page":"7925","DOI":"10.1038\/s41598-019-44524-5","article-title":"Role of deleterious single nucleotide variants in the coding regions of TNFAIP3 for Japanese autoimmune hepatitis with cirrhosis","volume":"9","author":"Higuchi","year":"2019","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.cld.2023.06.003_bib33","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hep.510250211","article-title":"Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis","volume":"25","author":"Czaja","year":"1997","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2023.06.003_bib34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/jhg.2016.155","article-title":"Association of a single nucleotide polymorphism upstream of ICOS with Japanese autoimmune hepatitis type 1","volume":"62","author":"Higuchi","year":"2017","journal-title":"J\u00a0Hum Genet"},{"issue":"8","key":"10.1016\/j.cld.2023.06.003_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071382","article-title":"Association of STAT4 polymorphisms with susceptibility to type-1 autoimmune hepatitis in the Japanese population","volume":"8","author":"Migita","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.cld.2023.06.003_bib36","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.5604\/01.3001.0012.7202","article-title":"Association of interleukin-6 and interleukin-1 family gene polymorphisms in autoimmune hepatitis","volume":"17","author":"Yousefi","year":"2018","journal-title":"Ann Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2023.06.003_bib37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.clinre.2018.07.004","article-title":"Association of IL-10 and TGF-beta cytokine gene polymorphisms with autoimmune hepatitis","volume":"43","author":"Yousefi","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2023.06.003_bib38","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1586\/17474124.2016.1139449","article-title":"IL4 gene polymorphisms in Iranian patients with autoimmune hepatitis","volume":"10","author":"Yousefi","year":"2016","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2023.06.003_bib39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.clinre.2017.06.005","article-title":"Autoimmune hepatitis association with single nucleotide polymorphism of interleukin-2, but not interferon-gamma","volume":"42","author":"Yousefi","year":"2018","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"8751","key":"10.1016\/j.cld.2023.06.003_bib40","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0140-6736(91)92858-Y","article-title":"Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals","volume":"337","author":"Vento","year":"1991","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cld.2023.06.003_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00281-012-0328-6","article-title":"Autoimmune manifestations in viral hepatitis","volume":"35","author":"Vergani","year":"2013","journal-title":"Semin Immunopathol"},{"issue":"3","key":"10.1016\/j.cld.2023.06.003_bib42","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/hep.20816","article-title":"LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry?","volume":"42","author":"Marceau","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2023.06.003_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/cei.13203","article-title":"Pathogens and autoimmune hepatitis","volume":"195","author":"Christen","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cld.2023.06.003_bib44","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-pathol-020117-043534","article-title":"Cellular and molecular mechanisms of autoimmune hepatitis","volume":"13","author":"Webb","year":"2018","journal-title":"Annu Rev Pathol"},{"issue":"24","key":"10.1016\/j.cld.2023.06.003_bib45","doi-asserted-by":"crossref","first-page":"13578","DOI":"10.3390\/ijms222413578","article-title":"Pathogenesis of autoimmune hepatitis-cellular and molecular mechanisms","volume":"22","author":"Sirbe","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1\u20133","key":"10.1016\/j.cld.2023.06.003_bib46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0300-483X(94)03010-Y","article-title":"Molecular mimicry in halothane hepatitis: biochemical and structural characterization of lipoylated autoantigens","volume":"97","author":"Gut","year":"1995","journal-title":"Toxicology"},{"issue":"8","key":"10.1016\/j.cld.2023.06.003_bib47","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/gut.22.8.669","article-title":"Oxidative metabolism of halothane in the production of altered hepatocyte membrane antigens in acute halothane-induced hepatic necrosis","volume":"22","author":"Neuberger","year":"1981","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.cld.2023.06.003_bib48","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1056\/NEJM198007103030202","article-title":"Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis","volume":"303","author":"Vergani","year":"1980","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cld.2023.06.003_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41577-022-00727-y","article-title":"The impact of the gut microbiome on extra-intestinal autoimmune diseases","volume":"23","author":"Miyauchi","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.cld.2023.06.003_bib50","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gutjnl-2018-317836","article-title":"Alterations of gut microbiome in autoimmune hepatitis","volume":"69","author":"Wei","year":"2020","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.cld.2023.06.003_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8071011","article-title":"Autoimmune hepatitis: shifts in gut microbiota and metabolic pathways among egyptian patients","volume":"8","author":"Elsherbiny","year":"2020","journal-title":"Microorganisms"},{"issue":"12","key":"10.1016\/j.cld.2023.06.003_bib52","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/apt.15754","article-title":"A\u00a0disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis","volume":"51","author":"Liwinski","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.cld.2023.06.003_bib53","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/hep.27998","article-title":"A\u00a0novel \"humanized mouse\" model for autoimmune hepatitis and the association of gut microbiota with liver inflammation","volume":"62","author":"Yuksel","year":"2015","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cld.2023.06.003_bib54","doi-asserted-by":"crossref","first-page":"e0198757","DOI":"10.1371\/journal.pone.0198757","article-title":"Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease","volume":"13","author":"Abe","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cld.2023.06.003_bib55","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3389\/fcimb.2020.00342","article-title":"Fecal microbiomes distinguish patients with autoimmune hepatitis from healthy individuals","volume":"10","author":"Lou","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"10.1016\/j.cld.2023.06.003_bib56","first-page":"5153","article-title":"Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis","volume":"8","author":"Lin","year":"2015","journal-title":"Int J Clin Exp Path"},{"key":"10.1016\/j.cld.2023.06.003_bib57","doi-asserted-by":"crossref","first-page":"115597","DOI":"10.1016\/j.taap.2021.115597","article-title":"Gut microbiome-host interactions in driving environmental pollutant trichloroethene-mediated autoimmunity","volume":"424","author":"Wang","year":"2021","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.cld.2023.06.003_bib58","doi-asserted-by":"crossref","first-page":"569104","DOI":"10.3389\/fimmu.2020.569104","article-title":"Bifidobacterium animalisssp. lactis 420 mitigates autoimmune hepatitis through regulating intestinal barrier and liver immune cells","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.cld.2023.06.003_bib59","doi-asserted-by":"crossref","first-page":"624360","DOI":"10.3389\/fimmu.2021.624360","article-title":"Leaky gut driven by dysbiosis augments activation and accumulation of liver macrophages via RIP3 signaling pathway in autoimmune hepatitis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"issue":"6380","key":"10.1016\/j.cld.2023.06.003_bib60","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aar7201","article-title":"Translocation of a gut pathobiont drives autoimmunity in mice and humans","volume":"359","author":"Vieira","year":"2018","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.cld.2023.06.003_bib61","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.chom.2022.05.006","article-title":"Tet2 deficiency drives liver microbiome dysbiosis triggering Tc1 cell autoimmune hepatitis","volume":"30","author":"Pandey","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cld.2023.06.003_bib62","doi-asserted-by":"crossref","first-page":"104575","DOI":"10.1016\/j.cellimm.2022.104575","article-title":"Methyl butyrate attenuates concanavalin A-induced autoimmune hepatitis by inhibiting Th1-cell activation and homing to the liver","volume":"378","author":"Yang","year":"2022","journal-title":"Cell Immunol"},{"issue":"3","key":"10.1016\/j.cld.2023.06.003_bib63","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.27884","article-title":"In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression","volume":"62","author":"Liberal","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2023.06.003_bib64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","article-title":"Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease","volume":"41","author":"Longhi","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.06.003_bib65","first-page":"3753081","article-title":"The imbalance between Foxp3(+)Tregs and Th1\/Th17\/Th22 cells in patients with newly diagnosed autoimmune hepatitis","volume":"2018","author":"Ma","year":"2018","journal-title":"J Immunol Res"},{"issue":"7\u20138","key":"10.1016\/j.cld.2023.06.003_bib66","doi-asserted-by":"crossref","first-page":"e3023","DOI":"10.1002\/jgm.3023","article-title":"Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+T cell function","volume":"20","author":"Ai","year":"2018","journal-title":"J Gene Med"},{"issue":"5","key":"10.1016\/j.cld.2023.06.003_bib67","first-page":"682","article-title":"Assessment of intrahepatic regulatory T\u00a0cells in children with autoimmune hepatitis","volume":"15","author":"Behairy","year":"2016","journal-title":"Ann Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2023.06.003_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181107","article-title":"Pediatric autoimmune hepatitis shows a disproportionate decline of regulatory T cells in the liver and of IL-2 in the blood of patients undergoing therapy","volume":"12","author":"Diestelhorst","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cld.2023.06.003_bib69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jhep.2012.02.029","article-title":"FOXP3+ regulatory T\u00a0cells in autoimmune hepatitis are fully functional and not reduced in frequency","volume":"57","author":"Peiseler","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2023.06.003_bib70","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.23792","article-title":"A\u00a0multifaceted imbalance of T\u00a0cells with regulatory function characterizes Type 1 autoimmune hepatitis","volume":"52","author":"Ferri","year":"2010","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2023.06.003_bib71","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1038\/s41419-017-0010-y","article-title":"Increased apoptosis of regulatory T cells in patients with active autoimmune hepatitis","volume":"8","author":"John","year":"2017","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.cld.2023.06.003_bib72","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2005.05.001","article-title":"Effect of CD4+CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis","volume":"25","author":"Longhi","year":"2005","journal-title":"J\u00a0Autoimmun"},{"issue":"7","key":"10.1016\/j.cld.2023.06.003_bib73","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.4049\/jimmunol.176.7.4484","article-title":"Functional study of CD4(+)CD25(+) regulatory T\u00a0cells in health and autoimmune hepatitis","volume":"176","author":"Longhi","year":"2006","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.cld.2023.06.003_bib74","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/hep.28517","article-title":"Human intrahepatic regulatory T Cells are functional, require il-2 from effector cells for survival, and are susceptible to fas ligand-mediated apoptosis","volume":"64","author":"Chen","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2023.06.003_bib75","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/annrheumdis-2018-214229","article-title":"Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial","volume":"78","author":"Rosenzwajg","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cld.2023.06.003_bib76","doi-asserted-by":"crossref","first-page":"102591","DOI":"10.1016\/j.jaut.2020.102591","article-title":"Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis","volume":"117","author":"Buitrago-Molina","year":"2021","journal-title":"J Autoimmun"},{"issue":"4","key":"10.1016\/j.cld.2023.06.003_bib77","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jhep.2012.05.022","article-title":"Regulatory T\u00a0cells in autoimmune hepatitis","volume":"57","author":"Longhi","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2023.06.003_bib78","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jhep.2012.06.037","article-title":"Regulatory T\u00a0cell defects in adult autoimmune hepatitis","volume":"57","author":"Ferri","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.06.003_bib79","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coph.2016.04.001","article-title":"Immunosuppressive activities of adenosine in cancer","volume":"29","author":"Allard","year":"2016","journal-title":"Curr Opin Pharmacol"},{"issue":"3","key":"10.1016\/j.cld.2023.06.003_bib80","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.26583","article-title":"Dysfunctional CD39(POS) regulatory T\u00a0cells and aberrant control of T-helper Type 17 Cells in autoimmune hepatitis","volume":"59","author":"Grant","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2023.06.003_bib81","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jhep.2020.06.044","article-title":"Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis","volume":"74","author":"Vuerich","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2023.06.003_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/ni.1915","article-title":"Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T\u00a0cell-like and Foxp3(+) regulatory T\u00a0cells","volume":"11","author":"Gandhi","year":"2010","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.cld.2023.06.003_bib83","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2249.1991.tb08164.x","article-title":"Clonal analysis of liver-infiltrating T\u00a0cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis","volume":"84","author":"Lohr","year":"1991","journal-title":"Clin Exp Immunol. May"},{"issue":"8730","key":"10.1016\/j.cld.2023.06.003_bib84","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/0140-6736(90)93306-A","article-title":"T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis","volume":"336","author":"Wen","year":"1990","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cld.2023.06.003_bib85","first-page":"1416","article-title":"Autoreactive CD4(+) LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis","volume":"24","author":"Lohr","year":"1996","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2023.06.003_bib86","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.4049\/jimmunol.1900124","article-title":"TNF-producing Th1 cells are selectively expanded in liver infiltrates of patients with autoimmune hepatitis","volume":"203","author":"Bovensiepen","year":"2019","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.cld.2023.06.003_bib87","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.25682","article-title":"The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9\/tim-3 pathway","volume":"56","author":"Liberal","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.003_bib88","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev-immunol-101819-092536","article-title":"IL-17 in the pathogenesis of disease: good intentions gone awry","volume":"39","author":"Majumder","year":"2021","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"10.1016\/j.cld.2023.06.003_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018909","article-title":"Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression","volume":"6","author":"Zhao","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cld.2023.06.003_bib90","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2174\/1386207322666190402160455","article-title":"Expression and Significance of Th17 cells and related factors in patients with autoimmune hepatitis","volume":"22","author":"An","year":"2019","journal-title":"Comb Chem High Throughput Screen"},{"key":"10.1016\/j.cld.2023.06.003_bib91","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jaut.2016.05.005","article-title":"CD39 mediated regulation of Th17-cell effector function is impaired in juvenile autoimmune liver disease","volume":"72","author":"Liberal","year":"2016","journal-title":"J\u00a0Autoimmun"},{"issue":"11","key":"10.1016\/j.cld.2023.06.003_bib92","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/apm.12457","article-title":"A\u00a0molecular marker of disease activity in autoimmune liver diseases with histopathological correlation; FoXp3\/ROR gamma t ratio","volume":"123","author":"Mitra","year":"2015","journal-title":"Apmis"},{"issue":"8","key":"10.1016\/j.cld.2023.06.003_bib93","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/hep4.1202","article-title":"Immune alterations in patients with type 1 autoimmune hepatitis persist upon standard immunosuppressive treatment","volume":"2","author":"Renand","year":"2018","journal-title":"Hepatol Commun"},{"issue":"12","key":"10.1016\/j.cld.2023.06.003_bib94","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/adc.67.12.1447","article-title":"Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis","volume":"67","author":"Senaldi","year":"1992","journal-title":"Arch Dis Child"},{"issue":"6","key":"10.1016\/j.cld.2023.06.003_bib95","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1600-0676.1998.tb00823.x","article-title":"Perforin and granzyme B lytic protein expression during chronic viral and autoimmune hepatitis","volume":"18","author":"Tordjmann","year":"1998","journal-title":"Liver"},{"issue":"8","key":"10.1016\/j.cld.2023.06.003_bib96","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/0960327115607078","article-title":"Bcl-2 and Fas expression in peripheral blood leukocytes of patients with alcoholic and autoimmune liver disorders","volume":"35","author":"Zwolak","year":"2016","journal-title":"Hum Exp Toxicol"},{"issue":"1","key":"10.1016\/j.cld.2023.06.003_bib97","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1440-1746.2000.02044.x","article-title":"Increase in CD95 (Fas\/APO-1)-positive CD4(+) and CD8(+) T\u00a0cells in peripheral blood derived from patients with autoimmune hepatitis or chronic hepatitis C with autoimmune phenomena","volume":"15","author":"Ogawa","year":"2000","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2023.06.003_bib98","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.21658","article-title":"Cytochrome P450IID6-specific CD8 T\u00a0cell immune responses mirror disease activity in autoimmune hepatitis type 2","volume":"46","author":"Longhi","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.003_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2014.00400","article-title":"Gamma delta T-lymphocytes in hepatitis C and chronic liver disease","volume":"5","author":"Rajoriya","year":"2014","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.cld.2023.06.003_bib100","first-page":"988","article-title":"Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases","volume":"23","author":"Martins","year":"1996","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2023.06.003_bib101","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2249.1992.tb06881.x","article-title":"Elevation of activated gamma delta T\u00a0cell receptor bearing T lymphocytes in patients with autoimmune chronic liver disease","volume":"89","author":"Wen","year":"1992","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"10.1016\/j.cld.2023.06.003_bib102","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1600-0463.2009.02540.x","article-title":"Liver distribution of gamma delta-T-cells in patients with chronic hepatitis of different etiology","volume":"117","author":"Kasper","year":"2009","journal-title":"Apmis"},{"key":"10.1016\/j.cld.2023.06.003_bib103","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3389\/fimmu.2019.01065","article-title":"Inflammatory phenotype of intrahepatic sulfatide-reactive type II NKT cells in humans with autoimmune hepatitis","volume":"10","author":"Sebode","year":"2019","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.cld.2023.06.003_bib104","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jhep.2017.05.024","article-title":"Crosstalk between type II NKT cells and T\u00a0cells leads to spontaneous chronic inflammatory liver disease","volume":"67","author":"Weng","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2023.06.003_bib105","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/hep.27991","article-title":"Depletion of B cells induces remission of autoimmune hepatitis in mice through reduced antigen presentation and help to T\u00a0cells","volume":"62","author":"Beland","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2023.06.003_bib106","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.28001","article-title":"B\u00a0cells expressing CD11b effectively inhibit CD4+T-cell responses and ameliorate experimental autoimmune hepatitis in mice","volume":"62","author":"Liu","year":"2015","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cld.2023.06.003_bib107","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1111\/jcmm.14997","article-title":"Dysregulated TFR and TFH cells correlate with B-cell differentiation and antibody production in autoimmune hepatitis","volume":"24","author":"Ma","year":"2020","journal-title":"J\u00a0Cell Mol Med"},{"issue":"1","key":"10.1016\/j.cld.2023.06.003_bib108","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/jgh.13844","article-title":"Possible involvement of chemokine C-C receptor 7(-)programmed cell death-1(+) follicular helper T-cell subset in the pathogenesis of autoimmune hepatitis","volume":"33","author":"Kimura","year":"2018","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2023.06.003_bib109","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/liv.12245","article-title":"Tfh and plasma cells are correlated with hypergammaglobulinaemia in patients with autoimmune hepatitis","volume":"34","author":"Ma","year":"2014","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.cld.2023.06.003_bib110","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jmii.2019.06.007","article-title":"Exploration the significance of Tfh and related molecules on C57BL\/6 mice model of experimental autoimmune hepatitis","volume":"54","author":"Ma","year":"2021","journal-title":"J\u00a0Microbiol Immunol Infect"},{"issue":"1","key":"10.1016\/j.cld.2023.06.003_bib111","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41419-019-2217-6","article-title":"Critical roles of conventional dendritic cells in autoimmune hepatitis via autophagy regulation","volume":"11","author":"Fan","year":"2020","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.cld.2023.06.003_bib112","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/cei.12907","article-title":"Critical roles of conventional dendritic cells in promoting T\u00a0cell-dependent hepatitis through regulating natural killer T\u00a0cells","volume":"188","author":"Wang","year":"2017","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.cld.2023.06.003_bib113","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/liv.14246","article-title":"Deficiency of canonical Wnt\/beta-catenin signalling in hepatic dendritic cells triggers autoimmune hepatitis","volume":"40","author":"Tan","year":"2020","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.cld.2023.06.003_bib114","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.3892\/mmr.2015.3791","article-title":"Myeloid-derived suppressor cells suppress CD4(+) and CD8(+) T\u00a0cell responses in autoimmune hepatitis","volume":"12","author":"Li","year":"2015","journal-title":"Mol Med Rep"},{"issue":"1","key":"10.1016\/j.cld.2023.06.003_bib115","first-page":"99","article-title":"Experimental chronic active hepatitis in rabbits following immunization with human liver proteins","volume":"11","author":"Meyerzum","year":"1972","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.cld.2023.06.003_bib116","first-page":"381","article-title":"Purification and characterization of human liver-specific membrane lipoprotein (LSP)","volume":"27","author":"McFarlane","year":"1977","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.cld.2023.06.003_bib117","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/0016-5085(83)90085-9","article-title":"Experimental autoimmune hepatitis in mice after immunization with syngeneic liver proteins together with the polysaccharide of Klebsiella pneumoniae","volume":"84","author":"Kuriki","year":"1983","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2023.06.003_bib118","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/hep.1840110106","article-title":"Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity","volume":"11","author":"Lohse","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.003_bib119","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaut.2013.05.001","article-title":"Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6","volume":"44","author":"Hintermann","year":"2013","journal-title":"J\u00a0Autoimmun"},{"issue":"2","key":"10.1016\/j.cld.2023.06.003_bib120","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/hep.26380","article-title":"Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4(+) T\u00a0cells","volume":"58","author":"Hardtke-Wolenski","year":"2013","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2023.06.003_bib121","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1053\/j.gastro.2008.06.042","article-title":"Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T\u00a0cells and PD-1-mediated signaling","volume":"135","author":"Kido","year":"2008","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.cld.2023.06.003_bib122","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1172\/JCI65414","article-title":"Medullary thymic epithelial cell depletion leads to autoimmune hepatitis","volume":"123","author":"Bonito","year":"2013","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.cld.2023.06.003_bib123","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1172\/JCI115836","article-title":"A\u00a0T\u00a0cell-dependent experimental liver injury in mice inducible by concanavalin A","volume":"90","author":"Tiegs","year":"1992","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cld.2023.06.003_bib124","doi-asserted-by":"crossref","first-page":"108411","DOI":"10.1016\/j.intimp.2021.108411","article-title":"Pathogenesis of Concanavalin A induced autoimmune hepatitis in mice","volume":"102","author":"Hao","year":"2022","journal-title":"Int Immunopharmacol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326123000776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326123000776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:01:09Z","timestamp":1761069669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326123000776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":124,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1089326123000776"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2023.06.003","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune Hepatitis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2023.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}